세계의 혈관 실링 디바이스 시장 규모는 2024년에 20억 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 35억 달러에 달하며, 2025-2033년에 5.77%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 이 시장은 만성질환의 유병률 상승, 혈관 실링 디바이스를 중심으로 한 수술 기구의 기술 진보, 저침습 수술에 대한 선호도의 증가에 의해 추진되고 있습니다.
만성질환 증가
암, 심혈관 질환, 비만과 같은 만성질환의 빈도가 증가하고 있는 것이 혈관 밀봉 장비 시장 성장의 주요 촉진요인으로 작용하고 있습니다. 이러한 질환은 수술적 치료가 필요한 경우가 많기 때문에 수술의 효과와 안전성을 향상시키는 첨단 수술 장비에 대한 수요가 증가하고 있습니다. 미국 질병통제예방센터(Centers of Diseases Control and Prevention)에 따르면 미국에서는 약 1억 2,900만 명이 심장병, 암, 당뇨병, 비만, 고혈압 등 적어도 한 가지 이상의 주요 만성질환을 앓고 있는 것으로 추산됩니다. 또한 미국내 10대 사망 원인 중 5개는 예방 및 치료 가능한 만성질환이거나 예방 및 치료 가능한 만성질환과 밀접한 관련이 있습니다. 혈관 밀봉 장비는 혈관 및 조직 다발을 일관되게 밀봉하여 수술 중 출혈 및 수술 후 문제를 줄이기 위해 조직 조작 및 지혈을 수반하는 시술에서 특히 중요합니다. 전 세계에서 만성질환의 부담이 증가하고 고령화로 인해 외과적 치료의 필요성이 증가함에 따라 효과적인 혈관 밀봉 솔루션에 대한 수요가 증가하고 있습니다.
최소침습수술의 도입 증가
혈관 밀봉 장비 시장 전망을 긍정적으로 만드는 또 다른 중요한 요소는 최소 침습 수술(MIS)로의 전환입니다. 국립의학도서관에 따르면 2017년 980만 건의 입원환자 대수술실 시술이 분석되었으며, 그 중 11.1%가 MIS, 2.5%가 로봇지원 수술이었던 반면, 2018년에는 960만 건의 입원환자 수술실 시술(11.2%가 MIS, 2.9%가 로봇지원 수술)이 분석되었습니다. 복강경 수술이나 로봇 수술과 같은 최소침습 수술은 기존 개복 수술에 비해 수술 후 통증이 적고, 입원 기간이 짧고, 회복이 빠르며, 합병증 발생 가능성이 낮다는 등 다양한 장점이 있습니다. 혈관 밀봉 장비는 제한된 수술 부위에서 정확한 지혈이 가능하므로 MIS 수술에 필수적입니다. 환자 및 의료진 사이에서 최소침습 수술이 대중화되면서 첨단 혈관 밀봉 기술에 대한 수요가 증가하고 있습니다.
의료비 지출 증가
Centers for Medicare and Medicaid Services에 따르면 미국의 의료비 지출은 4.1% 증가하여 2022년 4조 5,000억 달러에 달할 것으로 예상되며, 2021년 3.2%보다 더 높은 성장률을 나타낼 것으로 예측됩니다. 년의 3.2% 증가를 상회합니다. 또한 2022년 보험 가입률은 92%(사상 최고치)에 달했습니다. 민간 의료보험 가입자는 290만 명 증가했고, 메디케이드 가입자는 610만 명 증가했습니다. 의료 시설에 대한 정부 및 민간 부문의 지출은 특히 신흥 국가에서 최첨단 기술을 갖춘 현대식 수술센터의 건설로 이어지고 있습니다. 이러한 확장은 고급 수술에 대한 접근성과 경제성을 개선하고, 혈관 밀봉 장비의 사용을 증가시켰습니다. 또한 선진국과 개발도상국 모두 수술 결과 개선과 환자 안전에 대한 관심이 높아지면서 고성능 수술 장비, 특히 혈관 밀봉 장비에 대한 수요가 증가하고 있습니다.
The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.
Increasing adoption of minimally invasive surgeries
Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
Instruments accounts for the majority of the market share
Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.
Laparoscopic surgery holds the largest share of the industry
Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Hospitals and specialty clinics represent the leading market segment
The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
North America leads the market, accounting for the largest vessel sealing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.
North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.